{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:41:52Z","timestamp":1787668912191,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Novel clinical outcome measures that accurately track Parkinson's disease (PD) progression are required to enhance patient care by improving physician decision-making and optimizing clinical trial design. The Parkinson's Disease Functional Impacts Digital Instrument (PD-FIDI) is a smartphone-app and wrist-worn wearable-based digital endpoint instrument designed to remotely measure PD functional impacts, including severity, progression, and functional changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Evaluate clinician- and patient-perspectives on the most relevant and meaningful aspects of PD to incorporate into the PD-FIDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An advisory panel of eight clinical experts guided a literature review of qualitative studies reporting patient perspectives on the everyday impacts of PD. Clinician perspectives were acquired from the same expert panel. The perspectives of people with PD were gathered through an online survey (\n                      <jats:italic>n<\/jats:italic>\n                      = 189 people with idiopathic PD;\n                      <jats:italic>n<\/jats:italic>\n                      = 13 people with PD and\n                      <jats:italic>GBA1<\/jats:italic>\n                      mutation). Clinician- and patient-perspectives were summarized through a meaningfulness classification scheme which scaled (low, medium, or high) the reported PD functional impacts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinicians and patients considered a subset of motor (tremor, rigidity\/stiffness, bradykinesia, global motor function, and hand and mobility difficulties) and non-motor (depression and fatigue) PD aspects to be most bothersome and meaningful if improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PD aspects identified as highly meaningful were incorporated into the PD-FIDI's design where technically viable, operationally feasible, and safe. Results support the evaluation of the PD-FIDI in an ongoing clinical study which will determine the instruments' analytical and clinical validity and usability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1677680","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:43:41Z","timestamp":1774021421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinician and patient perspectives on meaningful Parkinson's disease impacts for digital assessment"],"prefix":"10.3389","volume":"17","author":[{"given":"Andrew","family":"Pearlmutter","sequence":"first","affiliation":[{"name":"Research and Development, Sanofi","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ellis","sequence":"additional","affiliation":[{"name":"Koneksa Health","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Judith","family":"Peterschmitt","sequence":"additional","affiliation":[{"name":"Research and Development, Sanofi","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14802\/jmd.15003","article-title":"Many faces of Parkinson's disease: non-motor symptoms of Parkinson's disease","volume":"8","author":"Lee","year":"2015","journal-title":"J Mov Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1002\/ana.21461","article-title":"Why have we failed to achieve neuroprotection in Parkinson's disease?","volume":"64","author":"Olanow","year":"2008","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"810860","DOI":"10.3389\/fnagi.2022.810860","article-title":"The disease modification conundrum in Parkinson's Disease: failures and hopes","volume":"14","author":"Mari","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2020.08.038","article-title":"Digital phenotyping in Parkinson's disease: empowering neurologists for measurement-based care","volume":"80","author":"Bhidayasiri","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/mdc3.12239","article-title":"Developing a tool for remote digital assessment of Parkinson's disease","volume":"3","author":"Kassavetis","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12883-020-01996-7","article-title":"Parkinson's disease: current assessment methods and wearable devices for evaluation of movement disorder motor symptoms - a patient and healthcare professional perspective","volume":"20","author":"AlMahadin","year":"2020","journal-title":"BMC Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0151195","DOI":"10.1371\/journal.pone.0151195","article-title":"Unraveling the relationship between motor symptoms, affective states and contextual factors in Parkinson's disease: a feasibility study of the experience sampling method","volume":"11","author":"Broen","year":"2016","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/mds.28028","article-title":"Usability of the experience sampling method in Parkinson's disease on a group and individual level","volume":"35","author":"Mulders","year":"2020","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual Life Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/mds.22875","article-title":"Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times","volume":"25","author":"Zhao","year":"2010","journal-title":"Mov Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/mds.27790","article-title":"Measuring Parkinson's disease over time: the real-world within-subject reliability of the MDS-UPDRS","volume":"34","author":"Evers","year":"2019","journal-title":"Mov Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/j.1365-2648.2010.05313.x","article-title":"Unified Parkinson's disease rating scale-motor exam: inter-rater reliability of advanced practice nurse and neurologist assessments","volume":"66","author":"Palmer","year":"2010","journal-title":"J Adv Nurs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/jnnp.2006.111161","article-title":"The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine","volume":"78","author":"Hagell","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/mds.10438","article-title":"Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile","volume":"18","author":"Hagell","year":"2003","journal-title":"Mov Disord"},{"key":"B18","unstructured":"2024"},{"key":"B19","article-title":"Scaling the Roche Digital Health Technology Platform to Assess Disease Severity and Progression in Individuals with Parkinson's Disease [abstract]","author":"Popp","year":"2022","journal-title":"Movement Disorders"},{"key":"B20","year":"2021"},{"key":"B21","year":"2022"},{"key":"B22","doi-asserted-by":"publisher","first-page":"160011","DOI":"10.1038\/sdata.2016.11","article-title":"The mPower study, Parkinson disease mobile data collected using ResearchKit","volume":"3","author":"Bot","year":"2016","journal-title":"Sci Data"},{"key":"B23","unstructured":"ResearchKit framework programming guide\n          \n          \n          2024"},{"key":"B24","unstructured":"2024"},{"key":"B25","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"P GB, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov Disord"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e006434","DOI":"10.1136\/bmjopen-2014-006434","article-title":"Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease","volume":"4","author":"Deane","year":"2014","journal-title":"BMJ Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41687-020-00230-9","article-title":"Patients' experiences of Parkinson's disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson's disease","volume":"4","author":"Bonner","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.2522\/ptj.20150662","article-title":"Objective gait and balance impairments relate to balance confidence and perceived mobility in people With Parkinson disease","volume":"96","author":"Curtze","year":"2016","journal-title":"Phys Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.parkreldis.2018.03.027","article-title":"Relationship between the MDS-UPDRS and Quality of Life: a large multicenter study of 3206 patients","volume":"52","author":"Skorvanek","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"B32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ene.12349","article-title":"Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients","volume":"21","author":"Mart\u00ednez-Mart\u00edn","year":"2014","journal-title":"Eur J Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jns.2015.04.013","article-title":"Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease","volume":"353","author":"Skorvanek","year":"2015","journal-title":"J Neurol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2147\/NDT.S196930","article-title":"Patient and physician perceptions of disease management in Parkinson's disease: results from a US-based multicenter survey","volume":"15","author":"Hermanowicz","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JPD-225068","article-title":"Relative meaningfulness and impacts of symptoms in people with early-stage Parkinson's disease","volume":"13","author":"Mammen","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.21586","article-title":"Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients","volume":"22","author":"Martinez-Martin","year":"2007","journal-title":"Mov Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1038\/s41598-021-94255-9","article-title":"The severity progression of non-motor symptoms in Parkinson's disease: a 6-year longitudinal study in Taiwanese patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ana.24781","article-title":"Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's","volume":"80","author":"Liu","year":"2016","journal-title":"Ann Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/s1474-4422(17)30122-9","article-title":"Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts","volume":"16","author":"Liu","year":"2017","journal-title":"Lancet Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","article-title":"Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease","volume":"53","author":"Liu","year":"2021","journal-title":"Nat Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson's disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"B42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0191-8869(97)00193-1","article-title":"Effects of repeated administration of the Beck Depression Inventory and other measures of negative mood states","volume":"24","author":"Sharpe","year":"1998","journal-title":"Pers Individ Dif"},{"key":"B43","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1037\/pas0000915","article-title":"Longitudinal patterning of depression repeatedly assessed across time among youth: different trajectories in self-report questionnaires and diagnostic interviews","volume":"32","author":"Long","year":"2020","journal-title":"Psychol Assess"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.5664\/jcsm.9192","article-title":"Estimating sleep stages using cardiorespiratory signals: validation of a novel algorithm across a wide range of sleep-disordered breathing severity","volume":"17","author":"Bakker","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/biostatistics\/kxv047","article-title":"On the repeated measures designs and sample sizes for randomized controlled trials","volume":"17","author":"Tango","year":"2016","journal-title":"Biostatistics"},{"key":"B46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in Early-Stage Parkinson's Disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1038\/s41598-022-15874-4","article-title":"Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease","volume":"12","author":"Lipsmeier","year":"2022","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/biom10020335","article-title":"The Challenge of Disease-Modifying Therapies in Parkinson's Disease: role of CSF Biomarkers","volume":"10","author":"Paolini Paoletti","year":"2020","journal-title":"Biomolecules"},{"key":"B49","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00415-020-10162-5","article-title":"Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field","volume":"268","author":"Smedinga","year":"2021","journal-title":"J Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1677680\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:43:42Z","timestamp":1774021422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1677680\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":49,"alternative-id":["10.3389\/fneur.2026.1677680"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1677680","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"article-number":"1677680"}}